Reality star Khloe Kardashian’s appearance on "The View" talk show earned Biohaven Pharmaceuticals loads of media impressions and mentions last summer—but now it's earned the pharma company an FDA slapdown.
Kardashian appeared on the morning talk show last July just after she signed on as a Nurtec spokescelebrity. During the seven-minute segment, she talked about her daughter, her family’s reality series and her migraine headaches.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,